{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-071954","form_type":"8-K","ticker":"LMAT","cik":"0001158895","company_name":"LEMAITRE VASCULAR INC","filed_at":"2026-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.625963+00:00","generated_at":"2026-05-16T00:07:26.184619+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"LeMaitre Q4 2025 sales $64.5M (+16%), EPS $0.68 (+39%), raises dividend 25%","bullets":["Q4 2025 sales $64.5M (+16% YoY, +15% organic); diluted EPS $0.68 (+39%).","Gross margin 71.7% (+240 bps); operating income $18.8M (+47%).","Quarterly dividend increased 25% to $0.25/share; payable March 26, 2026 to holders of record March 12, 2026.","Board authorized $100M share repurchase program, expiring February 18, 2027.","FY2026 guidance: sales mid $280M (+12%), adj. op. income +21%, adj. EPS +22%."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-071954","json":"https://secwatch.observer/filing/0001193125-26-071954.json","markdown":"https://secwatch.observer/filing/0001193125-26-071954.md","text":"https://secwatch.observer/filing/0001193125-26-071954.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1158895/000119312526071954/0001193125-26-071954-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1158895/000119312526071954/d23187d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T00:07:26.184619+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}